These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6410642)

  • 1. Natural killer activity and low-affinity E rosettes in acute leukemias.
    Matera L; Giancotti FG
    Acta Haematol; 1983; 70(3):158-62. PubMed ID: 6410642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of natural killer cell defects in childhood acute lymphoblastic leukemia.
    Yamada S; Miyagawa Y; Komiyama A; Akabane T
    Jpn J Clin Oncol; 1984 Mar; 14(1):75-80. PubMed ID: 6608609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural cytotoxicity in adult acute leukemia.
    Sørskaar D; Førre O; Albrechtsen D; Stavem P
    Int Arch Allergy Appl Immunol; 1988; 86(2):190-5. PubMed ID: 3292440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysis of fresh human B-lymphocyte-derived leukemia cells by interferon-activated natural killer (NK) cells.
    Pattengale PK; Gidlund M; Nilsson K; Sundström C; Sällström J; Simonsson B; Wigzell H
    Int J Cancer; 1982 Jan; 29(1):1-7. PubMed ID: 6174459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer activity of pediatric patients with acute lymphoblastic leukemia in remission.
    Inada M; Okawa H; Suzuki M; Yata J
    Jpn J Clin Oncol; 1984 Sep; 14(3):335-45. PubMed ID: 6592376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of natural killers in acute leukemia in children].
    Blinov MN; Vartanian NL; Luganova IS; Klubovskaia NI; Alekseev NA
    Vopr Onkol; 1988; 34(4):421-5. PubMed ID: 3376454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of antileukemia cells' cytotoxic effector function. Implications for monitoring natural killer responses following allogeneic bone marrow transplantation.
    Delmon L; Ythier A; Moingeon P; Nowill A; Bayle C; Pico JL; Hayat M; Ritz J; Hercend T
    Transplantation; 1986 Sep; 42(3):252-6. PubMed ID: 3529526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human nonspecific killer cells].
    Thränhardt H; Zintl F; Milleck J; Jantscheff P; Hermann J; Fuchs D; Voigt P; Metz O; Löbe LP; Mohr F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):390-407. PubMed ID: 6182059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors.
    Mantovani A; Allavena P; Sessa C; Bolis G; Mangioni C
    Int J Cancer; 1980 May; 25(5):573-82. PubMed ID: 6154662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical signification of natural killer activity in B-cell chronic lymphocytic leukemia.
    Alvarez-Mon M; Casas J; Laguna R; Jordá J; Durantez A
    Eur J Haematol; 1987 Mar; 38(3):268-73. PubMed ID: 3496239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of IgG and IgM receptors on human peripheral natural killer cells measured on the level of the single effector cell.
    Jondal M; Merrill JE
    Eur J Immunol; 1981 Jul; 11(7):531-5. PubMed ID: 7286061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
    Sharma B; Vaziri ND
    Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood lymphoblastic leukemia with natural killer activity: establishment of the leukemia cell lines retaining the activity.
    Komiyama A; Kawai H; Miyagawa Y; Akabane T
    Blood; 1982 Dec; 60(6):1429-36. PubMed ID: 6958338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes: a regulatory role for the sheep red blood cell receptor.
    Fuson EW; Cole AJ; Hubbard RA
    J Clin Lab Immunol; 1985 Aug; 17(4):183-9. PubMed ID: 2999410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of natural killer function through activation of the T11 E rosette receptor.
    Schmidt RE; Michon JM; Woronicz J; Schlossman SF; Reinherz EL; Ritz J
    J Clin Invest; 1987 Jan; 79(1):305-8. PubMed ID: 3098784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional changes in the natural killer cells of patients with acute leukemia].
    Vartanian NL; Luganova IS; Blinov MN
    Eksp Onkol; 1989; 11(1):43-5. PubMed ID: 2924709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia.
    Ziegler HW; Kay NE; Zarling JM
    Int J Cancer; 1981 Mar; 27(3):321-7. PubMed ID: 6169660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
    Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
    Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.